Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Author(s) -
Daniel K. Nomura,
Brad E. Morrison,
Jacqueline L. Blankman,
Jonathan Z. Long,
Steven G. Kinsey,
Maria Cecília Garibaldi Marcondes,
Anna M. Ward,
Yun K. Hahn,
Aron H. Lichtman,
Bruno Conti,
Benjamin F. Cravatt
Publication year - 2011
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.1209200
Subject(s) - monoacylglycerol lipase , endocannabinoid system , 2 arachidonoylglycerol , phospholipase a2 , diacylglycerol lipase , cyclooxygenase , neuroprotection , arachidonic acid , anandamide , neuroinflammation , proinflammatory cytokine , enzyme , prostaglandin , chemistry , lipid signaling , pharmacology , biology , cannabinoid receptor , biochemistry , inflammation , receptor , antagonist , immunology
Phospholipase A(2)(PLA(2)) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins. Here, we show that a distinct pathway exists in brain, where monoacylglycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins. MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model. These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA(2). These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom